DK3473255T3 - Farmaceutisk formulering omfattende ciclesonid - Google Patents

Farmaceutisk formulering omfattende ciclesonid Download PDF

Info

Publication number
DK3473255T3
DK3473255T3 DK18204242.4T DK18204242T DK3473255T3 DK 3473255 T3 DK3473255 T3 DK 3473255T3 DK 18204242 T DK18204242 T DK 18204242T DK 3473255 T3 DK3473255 T3 DK 3473255T3
Authority
DK
Denmark
Prior art keywords
ciclesonide
pharmaceutical formulation
formulation including
pharmaceutical
including ciclesonide
Prior art date
Application number
DK18204242.4T
Other languages
Danish (da)
English (en)
Inventor
Michael Aven
Balazs Albrecht
Benjamin Franzmann
Matthias Hausmann
Janine Lamar
Ingo Lang
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Application granted granted Critical
Publication of DK3473255T3 publication Critical patent/DK3473255T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK18204242.4T 2012-12-21 2013-12-18 Farmaceutisk formulering omfattende ciclesonid DK3473255T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
EP13190393 2013-10-25
EP13808056.9A EP2934544B1 (en) 2012-12-21 2013-12-18 Pharmaceutical formulation comprising ciclesonide

Publications (1)

Publication Number Publication Date
DK3473255T3 true DK3473255T3 (da) 2022-04-04

Family

ID=49779929

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18204242.4T DK3473255T3 (da) 2012-12-21 2013-12-18 Farmaceutisk formulering omfattende ciclesonid
DK13808056.9T DK2934544T3 (en) 2012-12-21 2013-12-18 PHARMACEUTICAL FORMULA INCLUDING CICLESONID

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK13808056.9T DK2934544T3 (en) 2012-12-21 2013-12-18 PHARMACEUTICAL FORMULA INCLUDING CICLESONID

Country Status (10)

Country Link
US (3) US10925964B2 (2)
EP (2) EP2934544B1 (2)
AU (1) AU2013360692B2 (2)
CA (1) CA2888431C (2)
DK (2) DK3473255T3 (2)
ES (2) ES2909039T3 (2)
IN (1) IN2015DN02999A (2)
LT (2) LT3473255T (2)
MX (1) MX364652B (2)
WO (1) WO2014096116A1 (2)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015010842B1 (pt) 2012-12-21 2021-03-30 Boehringer Ingelheim Vetmedica Gmbh Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
LT3473255T (lt) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
ES2759247T3 (es) * 2014-06-18 2020-05-08 Boehringer Ingelheim Vetmedica Gmbh Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos
US20180126000A1 (en) 2016-06-02 2018-05-10 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
BR112020010694A2 (pt) 2017-12-01 2020-11-10 Abbvie Inc. agonista de receptor de glicocorticoides e imunoconjugados do mesmo

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) * 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
WO2004023984A2 (en) 2002-09-13 2004-03-25 Smith C Steven Novel composition and method for treatment of upper respiratory conditions
AU2004241746A1 (en) * 2003-05-22 2004-12-02 Nycomed Gmbh Salmeterol and ciclesonide combination
PT1670482E (pt) * 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070134165A1 (en) * 2004-04-20 2007-06-14 Altana Pharma Ag Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
CA2568834A1 (en) * 2004-06-29 2006-01-12 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and an anticholinergic
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
JP2012530567A (ja) 2009-06-25 2012-12-06 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング 吸入器
WO2014007767A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose and a ternary component
EA201590019A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
LT3473255T (lt) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
BR112015010842B1 (pt) 2012-12-21 2021-03-30 Boehringer Ingelheim Vetmedica Gmbh Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
HRP20201987T1 (hr) 2013-08-20 2021-02-05 Boehringer Ingelheim Vetmedica Gmbh Inhalator
EP3035885B1 (en) 2013-08-20 2019-12-25 Boehringer Ingelheim Vetmedica GmbH Inhaler
ES2759247T3 (es) 2014-06-18 2020-05-08 Boehringer Ingelheim Vetmedica Gmbh Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos

Also Published As

Publication number Publication date
US20210106685A1 (en) 2021-04-15
US11819549B2 (en) 2023-11-21
AU2013360692A1 (en) 2015-04-23
ES2909039T3 (es) 2022-05-05
DK2934544T3 (en) 2019-03-04
EP2934544B1 (en) 2018-11-07
IN2015DN02999A (2) 2015-09-25
CA2888431C (en) 2021-10-19
WO2014096116A1 (en) 2014-06-26
AU2013360692B2 (en) 2018-08-09
MX2015007731A (es) 2015-09-07
CA2888431A1 (en) 2014-06-26
EP3473255B1 (en) 2022-01-12
US10925964B2 (en) 2021-02-23
ES2706757T3 (es) 2019-04-01
US20240024482A1 (en) 2024-01-25
EP2934544A1 (en) 2015-10-28
EP3473255A1 (en) 2019-04-24
LT3473255T (lt) 2022-03-10
MX364652B (es) 2019-05-03
US20140179650A1 (en) 2014-06-26
LT2934544T (lt) 2019-02-25

Similar Documents

Publication Publication Date Title
LTPA2018511I1 (lt) Policikliniai karbamoilpiridino junginiai ir jų farmacinis panaudojimas
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
DK3639872T3 (da) Lægemiddeladministrationsanordning
PT2854768T (pt) Composições farmacêuticas de pemetrexed
EP2758052A4 (en) PHARMACEUTICAL COMPOSITIONS
CO6940426A2 (es) Formulaciones farmacéuticas
DK2897594T3 (da) Farmaceutisk sammensætning
SMT202000288T1 (it) Formulazione farmaceutica comprendente inositolo
CL2014003283A1 (es) Formulación farmacéutica.
DK2868318T4 (da) Injicerbar formulering
EP2815752A4 (en) ORAL PHARMACEUTICAL COMPOSITION
NO2020014I1 (no) ciclesonide
EP2815753A4 (en) ORAL PHARMACEUTICAL COMPOSITION
EP2883547A4 (en) MEDICINE
DK2854765T3 (da) Farmaceutisk pemetrexed-opløsning
ZA201405925B (en) Pharmaceutical formulation having improved stability
DK3473255T3 (da) Farmaceutisk formulering omfattende ciclesonid
CO7091176A2 (es) Diagnóstico farmacéutico
BR112015002646A2 (pt) composto e composição farmacêutica
IL235988A0 (en) Drug composition is based on genotype or phenotype
PL2908836T3 (pl) Formulacja farmaceutyczna zawierająca kurkuminę
EP2897590A4 (en) PHARMACEUTICAL COMPOSITION
BR302012003979S1 (pt) Configuração aplicada em fármaco
BR112014021433A2 (pt) formulações farmacêuticas
EP2851078A4 (en) PHARMACEUTICAL COMPOSITION